Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Government of Canada was posted on September 7, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Canadian Acute-Care Point Prevalence Survey (CAPPS)

Closed
1000252004International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Public Health Agency of Canada is seeking a qualified national organization or association specializing in medical microbiology or infectious disease medicine to implement the Canadian Acute-care hospital Point Prevalence Survey. This initiative aims to enhance the collection of data regarding healthcare-associated infections, antimicrobial resistance, and antimicrobial use across a representative sample of acute-care hospitals in Canada. A key component of the 2024 study is a pilot project designed to validate point prevalence data, bringing the program in line with international standards set by the Transatlantic Task Force on Antimicrobial Resistance. The primary goal of this project is to provide the agency with critical data to inform infection prevention and control programs and antimicrobial stewardship, ultimately reducing healthcare costs and improving patient care. Because healthcare is managed provincially and territorially, the contractor will serve as a vital intermediary to ensure national representation and the standardization of disease diagnosis definitions across different jurisdictions. This solicitation, managed by Health Canada, is focused on reducing the burden of antimicrobial resistant organisms within the Canadian healthcare system.

General Info

PHAC seeks a national organization to implement the Canadian Acute-care hospital Point Prevalence Survey.

Agency

Government of Canada → Health Canada

Place of Performance

*Canada, CAN

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Health Canada
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Health Canada
Office AddressN/A
Contacts
Lana IbrahimPoint of Contact

Full Description

Show more
Public Health Agency of Canada (PHAC) has conducted public health surveillance on healthcare-associated infections (HAIs). This work is used to inform best-practices designed to minimize the risk of antimicrobial resistant organisms (AROs) to Canadians, specifically through the implementation of hospital-specific infection prevention and control (IPC) programs and antimicrobial stewardship programs (ASP). In addition to active surveillance, the Canadian Nonsociomial Infection Surveillance Program (CNISP) collects data on healthcare-associated infections, antimicrobial resistant organisms and antimicrobial use via periodic point prevalence studies. To date, CNISP has conducted three point prevalence studies (2002, 2009 and 2017). The next point prevalence study is planned for 2024. In contrast to our partners in the Transatlantic Task Force on Antimicrobial Resistance, CNISP has yet to validate its point prevalence data. Thus, CNISP proposes as part of the 2024 point prevalence study, a pilot project that will provide the opportunity for a subset of hospitals completing the primary point prevalence study to conduct a validation study in parallel. The overall objective of this work is to improve PHAC’s access to HAI, antimicrobial resistance (AMR) and antimicrobial use (AMU) data through the implementation of the Canadian Acute-care hospital Point Prevalence Survey (CAPPS) from a nationally representative sample of acute-care hospitals across Canada. These data will assist PHAC in understanding the burden of of HAIs (including AROs) in order to inform IPC and ASP, help reduce the rates of HAIs (including AMR) in hospitals, reduce healthcare costs, and improve patient care. As the delivery of healthcare is primarilly conducted by provincial and territorial governments (i.e. PHAC has no direct access to eligible hospitals), and as the definition for disease diagnoses are not harmonized between jurisdictions, PHAC requires the involvement of an intermediary. The contractor is required to be an established national organization or association with specialization in medical microbiology or infectious disease medicine to ensure national representation and data standardization.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS